Schedule of Weighted Average Assumptions (Details) - Biostage 2013 Equity Incentive Plan [Member]	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.76%	2.59%
Expected volatility	126.16%	124.51%
Expected term (years)	5 years 10 months 24 days	5 years 6 months
Expected dividend yield	0.00%	0.00%